Some experts have raised concerned about 23andMe's new direct-to-consumer pharmacogenetic tests, Time reports.
The US Food and Drug Administration earlier this week gave 23andMe authorization to sell tests for 33 variants linked to the ability to break down certain drugs, as GenomeWeb has reported.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.
Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.
Vox explores a proposal to institute a lottery system to award grant funds.
In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.